NDRG4 Antikörper (AA 210-331)
Kurzübersicht für NDRG4 Antikörper (AA 210-331) (ABIN7165855)
Target
Alle NDRG4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 210-331
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Protein NDRG4 protein (210-331AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- NDRG4 (NDRG Family Member 4 (NDRG4))
-
Andere Bezeichnung
- NDRG4
-
Hintergrund
-
Background: Contributes to the maintenance of intracerebral BDNF levels within the normal range, which is necessary for the preservation of spatial learning and the resistance to neuronal cell death caused by ischemic stress (By similarity). May enhance growth factor-induced ERK1 and ERK2 phosphorylation, including that induced by PDGF and FGF. May attenuate NGF-promoted ELK1 phosphorylation in a microtubule-dependent manner.
Aliases: BDM1 antibody, Brain development-related molecule 1 antibody, KIAA1180 antibody, Ndrg4 antibody, NDRG4_HUMAN antibody, Protein NDRG4 antibody, SMAP 8 antibody, SMAP-8 antibody, Vascular smooth muscle cell-associated protein 8 antibody
-
UniProt
- Q9ULP0
Target
-